Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
13.27
-0.16 (-1.19%)
At close: Jun 9, 2026, 4:00 PM EDT
13.25
-0.02 (-0.15%)
After-hours: Jun 9, 2026, 7:00 PM EDT
Core Laboratories Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 29.57 | 30.39 | 32.15 | 37.03 | 39.32 | 20.22 |
Depreciation & Amortization | 14.7 | 14.65 | 14.95 | 15.78 | 17.16 | 18.52 |
Stock-Based Compensation | 8.01 | 7.14 | 3.76 | 13.97 | 7.76 | 19.09 |
Other Adjustments | -4.7 | -0.62 | -2.35 | -13.22 | 5.4 | -0.69 |
Change in Receivables | 6 | -4.95 | -3.61 | -2.62 | -10.08 | -13.52 |
Changes in Inventories | -0.54 | 2.64 | 9.37 | -12.98 | -14.86 | -4.55 |
Changes in Accounts Payable | 0.35 | 0.48 | 0.52 | -12.88 | 15.37 | 6.57 |
Changes in Accrued Expenses | -4.17 | -2.71 | 2.53 | -0.38 | -1.3 | -8.76 |
Changes in Unearned Revenue | -5.06 | -3.78 | 4.58 | -1.19 | -1.82 | 2.31 |
Changes in Other Operating Activities | -10.04 | -6.21 | -5.5 | 1.26 | -12.33 | -2.61 |
Operating Cash Flow | 34.34 | 37.03 | 56.39 | 24.79 | 24.96 | 36.58 |
Operating Cash Flow Growth | -40.30% | -34.33% | 127.47% | -0.67% | -31.77% | -36.79% |
Capital Expenditures | -15.9 | -14.59 | -13.03 | -10.58 | -10.22 | -13.54 |
Sale of Property, Plant & Equipment | 3.28 | 3.02 | 1.74 | 0.49 | 1.89 | 0.68 |
Purchases of Intangible Assets | -0.15 | -0.15 | 0.02 | 0.07 | -0.03 | -0.32 |
Proceeds from Sale of Intangible Assets | 0.01 | - | - | - | - | - |
Purchases of Investments | - | - | - | - | 3.68 | - |
Proceeds from Sale of Investments | 0.39 | 0.78 | 2.78 | 3.38 | - | 1.36 |
Payments for Business Acquisitions | -0.93 | -1.24 | - | - | - | - |
Proceeds from Business Divestments | - | - | - | - | 0.24 | 0.87 |
Other Investing Activities | 6.83 | 9.95 | 2.1 | - | 0.58 | 0.73 |
Investing Cash Flow | -6.39 | -2.23 | -6.39 | -6.65 | -3.86 | -10.22 |
Long-Term Debt Issued | 101 | 48 | 44 | 202 | 116 | 155 |
Long-Term Debt Repaid | -110 | -63 | -82 | -211 | -131 | -226 |
Net Long-Term Debt Issued (Repaid) | -9 | -15 | -38 | -9 | -15 | -71 |
Issuance of Common Stock | - | - | - | - | - | 60 |
Repurchase of Common Stock | -14.4 | -12.43 | -5.31 | -2.2 | -3.9 | -8.26 |
Net Common Stock Issued (Repurchased) | -14.4 | -12.43 | -5.31 | -2.2 | -3.9 | 51.74 |
Common Dividends Paid | -1.86 | -1.87 | -1.88 | -1.87 | -1.85 | -1.83 |
Other Financing Activities | -0.26 | -1.96 | -0.78 | -5.38 | -2.62 | -1.37 |
Financing Cash Flow | -27.23 | -31.26 | -45.96 | -18.45 | -23.38 | -22.46 |
Net Cash Flow | 0.71 | 3.55 | 4.04 | -0.31 | -2.28 | 3.9 |
Free Cash Flow | 18.44 | 22.44 | 43.36 | 14.21 | 14.74 | 23.04 |
Free Cash Flow Growth | -17.85% | -48.24% | 205.14% | -3.60% | -36.02% | -49.90% |
FCF Margin | 3.51% | 4.26% | 8.28% | 2.79% | 3.01% | 4.90% |
Free Cash Flow Per Share | 0.39 | 0.48 | 0.91 | 0.30 | 0.31 | 0.49 |
Levered Free Cash Flow | -0.63 | 5.15 | 6.82 | 6.73 | -3.54 | -53.34 |
Unlevered Free Cash Flow | 16.36 | 27.87 | 54.18 | 28.14 | 19.26 | 23.28 |